Top Markets
Coin of the day
Accustem Sciences Inc. Accustem Sciences Inc.

Accustem Sciences Inc.

ACUT
Rank in Stocks #36602
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Share Price
$0.156
Last synced: 2026-08-13
Market Cap
$2.51M
Change (1 day)
2.97%
Change (1 year)
-91.28%
Country
US
Trade Accustem Sciences Inc. (ACUT)

Category

P/B ratio for Accustem Sciences Inc. (ACUT)
P/B ratio as of 2026 TTM: 0
According to Accustem Sciences Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Accustem Sciences Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE